NCT00199602View on ClinicalTrials.gov

Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2010

Conditions
Cancer
Interventions
DRUG

warfarine - low molecular heparin

Trial Locations (1)

87000

Oncologie Médicale, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT00199602 - Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients | Biotech Hunter | Biotech Hunter